Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cost-effectiveness of Palivizumab for Respiratory Syncytial Virus: A Systematic Review.

Mac S, Sumner A, Duchesne-Belanger S, Stirling R, Tunis M, Sander B.

Pediatrics. 2019 May;143(5). pii: e20184064. doi: 10.1542/peds.2018-4064. Review.

PMID:
31040196
2.

The economic burden of Lyme disease and the cost-effectiveness of Lyme disease interventions: A scoping review.

Mac S, da Silva SR, Sander B.

PLoS One. 2019 Jan 4;14(1):e0210280. doi: 10.1371/journal.pone.0210280. eCollection 2019.

3.

Cost-effectiveness of a high-intensity rapid access outpatient stroke rehabilitation program.

Tam A, Mac S, Isaranuwatchai W, Bayley M.

Int J Rehabil Res. 2019 Mar;42(1):56-62. doi: 10.1097/MRR.0000000000000327.

PMID:
30431508
4.

Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics.

Arpin CC, Mac S, Jiang Y, Cheng H, Grimard M, Page BD, Kamocka MM, Haftchenary S, Su H, Ball DP, Rosa DA, Lai PS, Gómez-Biagi RF, Ali AM, Rana R, Hanenberg H, Kerman K, McElyea KC, Sandusky GE, Gunning PT, Fishel ML.

Mol Cancer Ther. 2016 May;15(5):794-805. doi: 10.1158/1535-7163.MCT-15-0003. Epub 2016 Feb 12.

5.

Enhanced targeting of stem-like solid tumor cells with radiation and natural killer cells.

Ames E, Canter RJ, Grossenbacher SK, Mac S, Smith RC, Monjazeb AM, Chen M, Murphy WJ.

Oncoimmunology. 2015 Jun 5;4(9):e1036212. eCollection 2015 Sep.

6.

NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype.

Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ.

J Immunol. 2015 Oct 15;195(8):4010-9. doi: 10.4049/jimmunol.1500447. Epub 2015 Sep 11.

7.

Anti-proliferative but not anti-angiogenic tyrosine kinase inhibitors enrich for cancer stem cells in soft tissue sarcoma.

Canter RJ, Ames E, Mac S, Grossenbacher SK, Chen M, Li CS, Borys D, Smith RC, Tellez J, Sayers TJ, Monjazeb AM, Murphy WJ.

BMC Cancer. 2014 Oct 10;14:756. doi: 10.1186/1471-2407-14-756.

8.

Short interfering RNA guide strand modifiers from computational screening.

Onizuka K, Harrison JG, Ball-Jones AA, Ibarra-Soza JM, Zheng Y, Ly D, Lam W, Mac S, Tantillo DJ, Beal PA.

J Am Chem Soc. 2013 Nov 13;135(45):17069-77. doi: 10.1021/ja4079754. Epub 2013 Nov 5.

9.

Dermal equivalents in oncology: benefit of one-stage procedure.

Pauchot J, Elkhyat A, Rolin G, Mac S, Grumblat A, Fotso A, Humbert P, Tropet Y.

Dermatol Surg. 2013 Jan;39(1 Pt 1):43-50. doi: 10.1111/dsu.12044. Epub 2012 Nov 27.

PMID:
23190429
10.

Cutaneous differences between Black, African or Caribbean Mixed-race and Caucasian women: biometrological approach of the hydrolipidic film.

Fotoh C, Elkhyat A, Mac S, Sainthillier JM, Humbert P.

Skin Res Technol. 2008 Aug;14(3):327-35. doi: 10.1111/j.1600-0846.2008.00299.x.

PMID:
19159380
11.

Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes.

Blonde L, Klein EJ, Han J, Zhang B, Mac SM, Poon TH, Taylor KL, Trautmann ME, Kim DD, Kendall DM.

Diabetes Obes Metab. 2006 Jul;8(4):436-47.

PMID:
16776751
12.

Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin.

Riddle MC, Henry RR, Poon TH, Zhang B, Mac SM, Holcombe JH, Kim DD, Maggs DG.

Diabetes Metab Res Rev. 2006 Nov-Dec;22(6):483-91.

PMID:
16634116
13.

Direct recruitment of N-myc to target gene promoters.

Mac SM, D'Cunha CA, Farnham PJ.

Mol Carcinog. 2000 Oct;29(2):76-86.

PMID:
11074604
14.

CAD, a c-Myc target gene, is not deregulated in Burkitt's lymphoma cell lines.

Mac SM, Farnham PJ.

Mol Carcinog. 2000 Feb;27(2):84-96.

PMID:
10657901
15.

Spatially restricted hypopigmentation associated with an Ednrbs-modifying locus on mouse chromosome 10.

Rhim H, Dunn KJ, Aronzon A, Mac S, Cheng M, Lamoreux ML, Tilghman SM, Pavan WJ.

Genome Res. 2000 Jan;10(1):17-29.

16.

Quantitative trait loci that modify the severity of spotting in piebald mice.

Pavan WJ, Mac S, Cheng M, Tilghman SM.

Genome Res. 1995 Aug;5(1):29-41.

17.

Editor/Author's Comment.

Barber B, Mac SS.

Orthopedics. 1982 Nov 1;5(11):1418-24. doi: 10.3928/0147-7447-19821101-03. No abstract available.

PMID:
24822765
18.

Rectus femoris muscle: an obstacle in reduction of acute traumatic anterior dislocation of hip in an adult.

Mac SS, Schein AJ.

Orthopedics. 1982 Jul;5(7):880-2. doi: 10.3928/0147-7447-19820701-08.

PMID:
24833505
19.

Superior dislocation of the patella with interlocking osteophytes.

Siegel MG, Mac SS.

J Trauma. 1982 Mar;22(3):253-4.

PMID:
7069814
20.

The early complications of subtalar dislocation.

Mac SS, Kleiger B.

Foot Ankle. 1981 Mar;1(5):270-4.

PMID:
7274906

Supplemental Content

Support Center